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Here, we evaluated Campylobacter contamination on chicken carcasses and phenotypic and genotypic
proﬁles of antimicrobial resistance of the isolated strains. A total of 95 of samples were collected from 19
slaughterhouses fromMinas Gerais - Brazil, and analyzed by MPN-PCR method. Campylobacterwas found
in 16.8% of samples with microbial load ranging from 60 to 184 MPN/carcass. All isolates were resistant to
at least 5 (31.2%) of the antimicrobials screened using the disk diffusion method. Thr-86-Ile gyrA mu-
tation, blaOxA-61 and tet(O) genes were found in 95%, 100% and 40% resistant isolates to ciproﬂoxacin,
ampicillin and tetracycline, respectively. Almost all isolates (90%) showed the three genes required to
synthesize the CmeABC efﬂux system. The use of efﬂux pump inhibitor (PAbN) resulted in a signiﬁcant
reduction in the MICs of antimicrobials (2e128 fold), indicating the importance of efﬂux systems in
conferring antimicrobial resistance. Campylobacter were detected at low concentrations in Brazilian
chicken carcasses. However, high-levels of antimicrobial resistance were observed and associated with
several mechanisms. This study provides a baseline survey on contamination of Campylobacter in Bra-
zilian chicken carcasses and its antimicrobial resistance, giving support for actions directed at reducing
this pathogen in the food chain.
© 2014 Elsevier Ltd. All rights reserved.1. Introduction
Campylobacter spp. has been recognized as a major cause of
foodborne disease worldwide. In 2011 the European Food Safety
Authority (EFSA, 2013) reported that the total number of campylo-
bacteriosis cases was 220,209 in the European Union, and it has fol-
lowed a signiﬁcant increasing trend in the last years. In the United
States, this pathogen was the second most common infection with
14.3 cases reported per 100,000 population in FoodNet in 2012 (CDC,
2013). Although it is generally recognized that there are many
contamination sources of this pathogen, chicken meat and by-tical Sciences, Jose Lourenço
io, Juiz de Fora, 36036-900,
5 32 2102 3893.
ungaro).products are the most important vehicles for human campylo-
bacteriosis (Humphrey, O'brien, & Madsen, 2007). Poultry are
considered natural reservoirs for this pathogen, and carcass
contaminationoccursmore frequentlyviacrop leakageandintestinal
rupture during the evisceration stage in slaughterhouses (Smith
et al., 2007). A world literature survey showed that about 58% of
chicken carcasses and by-products are contaminated by Campylo-
bacter spp., but greatvariations in theﬁndingswereobserved (Suzuki
& Yamamoto, 2009). Despite the importance of this pathogen, the
epidemiological and risk assessment studies are recent in Brazil, and
there are no legal standards yet established for its presence or counts
in foods. Researches in this ﬁeld become absolutely necessary in
Brazil because this country is the world's largest exporter of chicken
meat since2004and it is the thirdproducer, surpassedonlybyUnited
States and China. The largest chicken meat producing states are
Parana, Santa Catarina, Rio Grande do Sul, S~ao Paulo and Minas
Gerais, according to the 2014 annual report of Brazilian Poultry
H.M. Hungaro et al. / Food Control 51 (2015) 15e2216Association (UBABEF, 2014). More recently, concern regarding
Campylobacter contamination in foods has increased because of high
levels of antimicrobial resistance, including the frequent isolation of
multidrug-resistant strains (Mozina, Kurincic, Klancnik, & Mavri,
2011). Antimicrobial resistance among bacterial pathogens isolated
from foods has been attributed to the indiscriminate use of antimi-
crobials in animal husbandry for preventive or therapeutic purposes
as well as for increasing the growth rate of animals (Alfredson &
Korolik, 2007). The dissemination of resistant Campylobacter to
other environments via livestock and foods of animal origin may
contribute to the emergence of antimicrobial resistance in humans
and complicate effective clinical treatment of campylobacteriosis
(Aarestrup & Engberg, 2001). Multiple mechanisms for antibiotic
resistance are present in Campylobacter spp., which may be associ-
ated with mutational alteration or modiﬁcation of target molecules,
repression of uptake systems, activation of efﬂux pumps, and inac-
tivation of the antibiotic (Iovine, 2013). Among these, the CmeABC
efﬂux system plays a key role in resistance to a wide variety of
compounds including antibiotics, bile salts, dyes anddetergents, and
has been broadly studied and characterized as a potential target to
reduce antimicrobial resistance of Campylobacter spp. (Lin, Michel,&
Zhang, 2002).
Resistance of Campylobacter isolates from chicken and by-
products to antibiotics such as quinolones, macrolides, tetracycline
and ampicillin as well as the molecular mechanisms of this resis-
tance have been reported in several studies (Griggs et al., 2009;
Mackiw, Korsak, Rzewuska, Tomczuk, & Ro _zynek, 2012; Obeng
et al., 2012). However, there is a lack of information regarding the
molecular basis of antimicrobial resistance ofCampylobacter isolates
in Brazil. Most studies have focused on the prevalence of Campylo-
bacter in food and animals and its phenotypic proﬁles of antimi-
crobial resistance (Biasi, Freitas DeMacedo, ScaranelloMalaquias,&
Franchin, 2011; Kuana, Santos, et al., 2008; de Moura et al., 2013).
Therefore, to our knowledge, there are no published data about
genotypic resistance in Campylobacter isolates from chicken car-
casses in Brazil. The objectives of this study were to evaluate
Campylobacter contamination on chicken carcasses slaughtered in
Minas Gerais State - Brazil and to determinate phenotypic and
genotypic proﬁles of antimicrobial resistance of the isolated strains.
2. Materials and methods
2.1. Sample collection
A total of 95 chicken carcasses were collected from 19 slaugh-
terhouses localized inMinas Gerais state, Brazil, during January and
February 2012. This is the ﬁfth largest producer and exporting
Brazilian state of chicken meat, surpassing 930,000 and 185,000
tons of carcasses produced and exported in 2013, respectively
(UBABEF, 2014). All selected establishments were representative of
slaughterhouses located in Minas Gerais state, Brazil, regarding
slaughtering frequency, numbers of slaughtered poultry and
geographical distribution into state. They were previously selected
by simple random sampling, representing 56% of the total number
of federally inspected slaughterhouses in this Brazilian state. Five
samples were randomly selected from each slaughterhouse after
the chilling stage. Each carcass was aseptically packed in a sterile
plastic bag and transported to the laboratory under cooled condi-
tions. Upon arrival at the laboratory, the carcass samples were
weighed and subject to Campylobacter enumeration.
2.2. Enumeration of Campylobacter spp
Previously, each carcass was aseptically transferred into a new
sterile plastic bag, to which was added 200 ml of 0.1% bufferedpeptone water e BPW (Himedia, Mumbai, India), and vigorously
shaken by hand for 1 min. This chicken carcass rinse was serially
diluted (10-fold) using BPW and analyzed by the Most Probable
Number Method (MPN) as described by Scherer, Bartelt,
Sommerfeld, and Hildebrandt (2006a) with some modiﬁcations.
Brieﬂy, aliquots of 1ml from each dilution (direct homogenate, 101
and 102) were brought into three MPN-tubes containing 9 ml
Preston Enrichment Broth Base (Himedia, Mumbai, India) con-
taining 0.4% charcoal and supplemented with antibiotics (20mg l1
of trimethoprim lactate, 15 mg l1 of cephalothin, 20 mg l1 of
vancomycin, 2.500 UI l1 polymyxin B and 2mg l1 of amphotericin
Be SigmaeAldrich, Saint Louis, USA) and 5% reductive solution FBP
(0.5% of ferrous sulfate, sodiummetabisulﬁte, and sodium pyruvate
e Vetec, Rio de Janeiro, Brazil). The MPN-tubes were incubated
under microaerobic conditions (approximately 2% H2, 5% O2, 10%
CO2 and 83% N2) at 42 C for 24 h using an anaerobic chamber
(Forma 1025 Thermo Scientiﬁc, USA). Then, 10 ml from each tube
were streaked onto Campylobacter Agar Base (Himedia, Mumbai,
India) supplemented as previously described for Preston broth.
After an incubation time of 48 h at 42 C under microaerobic
conditions, plates were examined for presence of presumptive
colonies. At least ﬁve colonies per plate were selected, Gram
stained and examined by phase-contrast microscopy for typical
Campylobacter morphology. One colony per tube-NMP showing
typical cellular morphology was isolated and conﬁrmed using po-
lymerase chain reaction (PCR). After molecular conﬁrmation of
these colonies, the number of positive tubes at each dilution was
determined and the Campylobacter spp. counts present in the rinse
ﬂuid and, consequently, in the chicken carcass samples were
computed from the statistical MPN table of de Man (1983) (95%
conﬁdence interval).
2.3. Conﬁrmation and species identiﬁcation
The isolates were conﬁrmed and identiﬁed using genus- and
species-speciﬁc PCR assays. DNA extraction was carried out using a
boiled-cell method. Fresh cultures of isolates were suspended in
500 ml of sterile ultra-pure water and boiled at 95 C for 10 min.
After centrifugation at 13,000 g for 2 min, the supernatants were
collected and stored at20 C until use as template DNA in the PCR
reactions. Primer sequences for the 16S rRNA gene were used to
conﬁrm isolates as belonging to the Campylobacter genus. The
species were identiﬁed using primer sequences to detect hippuri-
case gene (hipO) speciﬁc for Campylobacter jejuni, and siderophore
transport gene (ceuE) speciﬁc for Campylobacter coli. Ampliﬁcations
were carried out in 25 ml reactions containing 2.5 ml of 10  PCR
buffer; 0.2 mmol l1 of deoxynucleoside triphosphate mix (ATP,
GTP, TTP and CTP); 0.4 mmol l1 of each primer; 2.5 U Taq PCR
polymerase (Promega, Madison, USA) and 2 ml of DNA preparation.
PCR reaction mixtures were heated at 96 C for 2 min as an initial
denaturation step followed by 30 cycles of denaturation at 95 C for
30 s, annealing for 45 s and extension 72 C for 60 s, and a ﬁnal
extension at 72 C for 5min. The sequence of primers and annealing
temperatures are listed in Table 1. The ampliﬁed products were
electrophoresed in 1.5% agarose gel containing ethidium bromide
(0.5 mg ml1) at 90 V for 40 min and visualized using a UV gel
documentation system (Quantum ST4 1100/26MX e Vilber Lour-
mat). A 100-bp DNA ladder (New England Biolabs, MA, USA) was
used as a standard for molecular size determinations.
2.4. Antibiotic susceptibility screening
The Campylobacter isolates were analyzed for antimicrobial
resistance using the agar disk diffusion method (CLSI, 2010). The
bacterial suspension was prepared in sterile saline solution (0.85%
Table 1
Primers and annealing temperature used for PCR in this study.
Target
gene
Primer sequence (50e30) Annealing
temperature
Reference
16S rRNA ATCTAATGGCTTAACCATTAAAC 59 C Denis et al. (1999)
GGACGGTAACTAGTTTAGTAT
hipO GAAGAGGGTTTGGGTGGTG 66 C Linton, Lawson,
Owen, and Stanley
(1997)
AGCTAGCTTCGCATAATAACTTG
ceuE TGATTTTATTATTTGTAGCAGCG 59 C Denis et al. (1999)
AATTGAAAATTGCTCCAACTATG
tet(O) GCGTTTTGTTTATGTGCG 54 C Pratt and Korolik
(2005)ATGGACAACCCGACAGAAG
blaOxA-61 AGAGTATAATACAAGCG 54 C Obeng et al. (2012)
TAGTGAGTTGTCAAGCC
gyrA TTTTTAGCAAAGATTCTGAT 48 C Zirnstein et al.
(1999)CAAAGCATCATAAACTGCAA
cmeA TTTGGATCCTTGATGGCTAAGGC
AACTTTC
50 C Lin et al. (2002)
CTCCAATTTCTTAAGCTTCGCTACCAA
cmeB Cja GGTACAGATCCTGATCAAGCC 50 C Lin et al. (2002)
AGGAATAAGTGTTGCACGGAAATT
cmeB Ccb TCCTAGCAGCACAATATG 54 C Obeng et al. (2012)
AGCTTCGATAGCTGCATC
cmeC GCTTGGATCCTTATCTTGGGAAAAA 50 C Lin et al. (2002)
TTTTTAAAGCTTTAAGGTAATTTTCTT
a Cj e C. jejuni.
b Cc e C. coli.
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ing 5% (v v1) sheep blood (MH blood) at 42 C for 24 h under
microaerobic conditions, and adjusted to an absorbance of 0.13 at
625 nm equivalent to 108 CFU ml1. Sterile cotton-tipped swabs
were used to transfer the inoculum onto MH blood plates to
produce a conﬂuent lawn of bacterial growth. After the inoculum
the plates were dried, the antibiotic disks were distributed over the
inoculated plates and these were incubated at 42 C for 48 h under
microaerobic conditions. The standard disks (Laborclin, Brazil)
containing the following antibiotics were used in this assay: cip-
roﬂoxacin (5 mg); nalidixic acid (30 mg); chloramphenicol (30 mg);
tetracycline (30 mg); gentamicin (10 mg); imipenem (10 mg);
ampicillin (10 mg); amoxicillin-clavulanic acid (10 mg); cephalothin
(30 mg); cefoxitin (30 mg); cefuroxime (30 mg); cefotaxime (30 mg);
ceftazidime (30 mg); cefepime (30 mg); trimethoprim-
sulfamethoxazole (23.75/1.25 mg); and erythromycin (15 mg). The
inhibition zone diameter obtained for these antibiotics was inter-
preted according to the breakpoints of the Clinical and Laboratory
Standards Institute for Enterobacteriaceae (CLSI, 2012), except for
erythromycin, which followed recommendations from The Euro-
pean Committee on Antimicrobial Susceptibility Testing e EUCAST
(http://www.eucast.org). The multiple antibiotic resistance (MAR)
index was calculated using the formula: a/b, where ‘a’ represents
the number of antibiotics to which a particular isolates was resis-
tant and ‘b’ the total number of antibiotics tested.2.5. Detection of antibiotic resistance genes
All the Campylobacter spp. were tested for the presence of tet(O),
blaOxA-61, gyrA (Thr-86-Ile mutation), cmeA, cmeB, and cmeC genes,
representing resistance to tetracycline, ampicillin and quinolones,
and CmeABC efﬂux system components, respectively. Each ampli-
ﬁcation reaction consisted of 2.5 ml of 10 PCR buffer; 0.2 mmol l1
of deoxynucleoside triphosphate mix (ATP, GTP, TTP and CTP);
0.4 mmol l1 of each primer; 2.5 U Taq PCR polymerase (Promega,
Madison, USA) and 2 ml of DNA preparation in a total reaction
volume of 25 ml. Simplex PCR assays for each gene were performed
using the following protocol: initial denaturation step of 96 C for1 min, followed by 30 cycles of 94 C for 30 s, speciﬁc annealing
temperature for 45 s, and 72 C for 1 min, and a ﬁnal extension step
at 72 C for 5 min. The sequence of primers and annealing tem-
peratures are listed in Table 1. The various amplicons were elec-
trophoresed and visualized as previously described.
2.6. Effect of efﬂux pump inhibitor on antimicrobial resistance
To investigate the contribution of efﬂux systems to resistance to
ampicillin, tetracycline, ciproﬂoxacin (SigmaeAldrich, Saint Louis,
USA) and bile salts (50% sodium cholate and 50% sodium deoxy-
cholate) (Becton Dickinson, Sparks, USA), the minimum inhibitory
concentrations (MIC) of these antimicrobials were determined in
all isolates using broth microdilution method (CLSI, 2010) in the
presence and absence of phenylalanineearginine b-naphthylamide
(PAbN) (SigmaeAldrich, Saint Louis, USA), a well-known efﬂux
pump inhibitor. The resistance assays were carried out in the 96-
well microtiter plates containing a ﬁnal volume of 100 ml per well
of Mueller Hinton broth (Himedia, Mumbai, India), with addition of
testing agents and ﬁnal inoculum of 105 CFU ml1. Two-fold serial
dilutions of antibiotics and bile salts were performed in the 96-well
plates for concentrations from 0.125 to 512 mg ml1 and
0.05e25 mg ml1, respectively. The PAbN was used to a ﬁnal con-
centration of 5 mg ml1 deﬁned by a preliminary microdilution
assay, and that had no inhibitory effects on bacterial growth for any
of the isolates. All of the MIC measurements were carried out in
triplicate, and positive and negative control wells were included.
The microtiter plates were incubated at 42 C for 48 h under
microaerobic conditions. Antibacterial activity was detected using a
colorimetric method by adding 30 ml of resazurin staining (0.01%)
aqueous solution in each well at the end of the incubation period
(at least 4 h before). The MICs were deﬁned as the lowest con-
centration of an antimicrobial where no metabolic activity is seen
after the incubation period, and they were determined by visual
observation on the basis of change in resazurin staining (living cells
e red; dead cells e blue) (Salvat, Antonnacci, Fortunato, Suarez, &
Godoy, 2001).
3. Results
A total number of 95 chicken carcasses from 19 slaughterhouses
were analyzed for the presence of Campylobacter spp. by the Most
Probable Number Method (MPN) associated with PCR conﬁrma-
tion. Sixteen samples from nine slaughterhouses were contami-
nated with microbial load ranging from 60 to 184 MPN carcass1
(Table 2). The overall contamination of chicken carcasses with
Campylobacter spp. was 16.8%, while the variation in positive
samples between the slaughterhouses was 20e60%. C. jejuni was
the species most frequently isolated, representing 93.8% of the
positive samples, whereas C. coliwas present in only one sample. A
total of 20 Campylobacter isolates made up of 18 C. jejuni and 2
C. coli isolates were obtained during sampling of typical colonies
grown on Campylobacter agar, corresponding to one isolate per
positive MPN-tube. An initial screening was performed to identify
the antimicrobial susceptibility of 20 Campylobacter strains against
16 antimicrobial agents by using the disk diffusion test. All isolates
were resistant to at least 5 (31.2%) of the antimicrobial agents tested
(Table 3). The highest resistance rates were noted for cephalospo-
rins (75e100%), ciproﬂoxacin (95%), nalidixic acid (95%) and
trimethoprim-sulfamethoxazole (100%). A similar level of resis-
tance was found for tetracycline (50%) and ampicillin (45%),
whereas a lower frequency of resistance was observed toward
amoxicillin-clavulanic acid (10%). On the other hand, no resistance
to chloramphenicol, gentamicin, imipenem, cefepime or erythro-
mycin was observed in any of the isolates. From these data, we
Table 2
Campylobacter spp. enumeration in chicken carcass samples using MPN technique.
Slaughterhouses Sample code Positive tubes (Dilution) MPN carcass1 (a)
D-10-1-102
A A52013 0-1-0 60
B B12013 1-0-0 72
C C42013 1-0-0 72
D D22013 2-0-0 184
D32013 1-0-0 72
D42013 1-1-0 148
E E22013 1-0-0 72
E32013 2-0-0 184
E52013 1-0-0 72
F F12013 2-0-0 184
F22013 1-0-0 72
F32013 1-0-0 72
G G12013 1-0-0 72
G52013 1-0-0 72
H H42013 1-0-0 72
I I52013 0-1-0 72
a Remaining samples showed Campylobacter spp. < 60 MPN carcass1.
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cillin) and bile salts for an investigation of the MICs and molecular
mechanisms contributing to antimicrobial resistance. Eight isolated
strains (40%) showed multi-drug resistance to ampicillin, tetracy-
cline and ciproﬂoxacin, and only one was sensitive to the three
antibiotics evaluated using the broth microdilution method
(Table 4). The MIC values of bile salts were highly variable, with
resistance rates between 0.390 and >25 mg ml1.
The results of phenotypic and genetic analysis of ciproﬂoxacin
susceptibility were sufﬁciently compatible, which was not
conﬁrmed for tetracycline and ampicillin. All ciproﬂoxacin-
resistant isolates had a point mutation Thr-86-Ile in gyrA gene of
DNA gyrase, except for one. In contrast, ten isolates were resistant
to tetracycline, but only four showed the tet(O) gene responsible for
the synthesis of a ribosomal protection protein that confers resis-
tance to the inhibitory effect of tetracycline on protein synthesis.Table 3
Antibiotic resistance proﬁle and multiple antibiotic resistance (MAR) index of
Campylobacter spp. isolates from chicken carcasses.
Strain Antibiotic resistant proﬁlea MAR index
A52013 CipNalCphCfoCrxCtxCazSut 0.50
B12013 CipNalTetAmpCfphCfoCrxCtxCazSut 0.63
C42013 CipNalTetCphCfoCrxCtxCazSut 0.56
D22013a CipNalTetAmpAmcCphCfoCrxCtxCazSut 0.69
D22013b CipNalTetAmpAmcCphCfoCrxCtxCazSut 0.69
D32013 CipNalAmpCphCfoCrxCtxCazSut 0.56
D42013a CipNalCphCfoCrxCtxCazSut 0.50
D42013b CipNalTetCphCfoCrxCtxCazSut 0.56
E22013 CipNalCphCfoCrxCtxCazSut 0.50
E32013a CipNalCphCfoCrxCazSut 0.44
E32013b CipNalCphCfoCrxCtxCazSut 0.50
E52013 CipNalTetCphCfoCrxCtxCazSut 0.56
F12013a CipNalTetAmpCphCfoCrxCtxCazSut 0.63
F12013b CipNalTetAmpCphCfoCrxCtxCazSut 0.63
F22013 CipNalTetAmpCphCfoCrxCtxCazSut 0.63
F32013 CipNalTetAmpCphCfoCrxCtxCazSut 0.63
G12013 CipNalCphCfoCrxSut 0.38
G52013 CipNalCphCfoCazSut 0.38
H42013 AmpCphCfoCrxSut 0.31
I52013 CipNalCphCfoCrxCazSut 0.44
a Ciproﬂoxacin (Cip) 5 mg; Nalidixic acid (Nal) 30 mg; Chloramphenicol (Clo) 30 mg;
Tetracycline (Tet) 30 mg; Gentamicin (Gen) 10 mg; Imipenem (Imp) 10 mg; Ampicillin
(Amp) 10 mg; Amoxicillin-clavulanic acid (Amc) 10 mg; Cephalothin (Cﬂ) 30 mg;
Cefoxitin (Cfo) 30 mg; Cefuroxime (Crx) 30 mg; Cefotaxime (Ctx) 30 mg; Ceftazidime
(Caz) 30 mg; Cefepime (Cpm) 30 mg; Trimethoprim-sulfamethoxazole (Sut) 23.75/
1.25 mg; Erythromycin (15 mg).Eight ampicillin-resistant isolates had a b-lactamase gene (blaOxA-
61), and this fact was also observed in ten sensitive isolates. More-
over, we also investigated the presence of the three genes that
encode the CmeABC efﬂux pump in Campylobacter spp. These three
genes, named cmeA, cmeB and cmeC, are arranged in an operon, and
encode for a periplasmic fusion protein, an inner membrane drug
transporter and an outer membrane protein, respectively. The cmeB
gene was found in all isolates, whereas cmeA was absent in two
isolates, one of which also showed no cmeC.
We used phenylalanine-arginine b-naphthylamide (PAbN) to
inhibit the CmeABC efﬂux system from Campylobacter isolates in
order to evaluate its effect on transport and resistance to antimi-
crobials. A correlation between this efﬂux system and resistance to
bile salts was observed for almost all isolates, whereas with other
antibiotics it was not so evident. Approximately 90, 55, 50 and 25%
of the isolates had transport of bile salts, ciproﬂoxacin, ampicillin
and tetracycline affected by PAbN, respectively. In combination
with PAbN, the MIC of ciproﬂoxacin, tetracycline and ampicillin
decreased from 2 to 8-fold for at least one of the isolates evaluated,
whereas for bile salts the decrease ranged from 2 to 128-fold
(Table 4). In addition, our results revealed that the absence of
cmeA and cmeC genes in two isolates did not inﬂuence the resis-
tance or transport of antimicrobials.
4. Discussion
Our results revealed low prevalence (16.8%) and low numbers
(60e184MPN carcass1) of Campylobacter spp. in chicken carcasses
obtained from slaughterhouses from Minas Gerais state, Brazil.
However, high resistance levels were observed in isolates for most
of the antibiotics, which proved to be caused by different molecular
mechanisms. Campylobacter contamination rates in this type of
food vary widely among countries, including Brazil. In a study of 13
European Union member states performed in 2011, the chicken
carcass contamination rate was 31.3% on average, but ranged from
3.2% to 84.6% (EFSA, 2013). Likewise, a literature survey of studies
performed in Brazil also showed that the occurrence of Campylo-
bacter spp. in chickens and by-products is widespread and ranges
from 6.7 to 100% (Franchin, Ogliari, & Batista, 2007; Gonçalves,
Yamanaka, Almeida, Chano, & Ribeiro, 2013; de Moura et al.,
2013; Oliveira & Oliveira, 2013). These variations in the preva-
lence rates of Campylobactermay be attributed to poultry breeding
methods, hygienic practices during slaughter, sampling strategies
and differences in analytical methods (Daskalov & Maramski,
2012).
Although many studies have conﬁrmed the prevalence of
Campylobacter in chicken carcasses, a quantitative risk assessment
of human campylobacteriosis depends on quantitative data, which
has been highlighted as a major hindrance in carrying out such an
assessment in developing countries (FAO/WHO, 2002). The choice
of most appropriate quantiﬁcation method depends on the ex-
pected level of Campylobacter in the sample examined and any
competitive bacterial ﬂora that may be present (Son, Englen,
Berrang, Fedorka-Cray, & Harrison, 2007). In this study, we chose
to use the Most Probable Number Method (MPN) associated with
identiﬁcation of Campylobacter by using a species-speciﬁc PCR
technique, which proved to be more suitable for enumeration of
this pathogen in Brazilian chicken carcasses. Our results showed
that the concentration of Campylobacter spp. in chicken carcasses
was low and similar to results reported by Tang et al. (2010), Wong
et al. (2007) and Scherer, Bartelt, Sommerfeld, and Hildebrandt
(2006b), who found the contamination of most samples ranging
from <100 MPN g1, <0.3 to 10 MPN g1, and <0.3 MPN g1,
respectively. However, even a low contamination of chicken car-
casses may be of concern to food safety authorities as because
Table 4
Minimum inhibitory concentrations (MICs) of antimicrobials in the absence and presence of the efﬂux pump inhibitor (EPI) against Campylobacter isolates and research on
resistance genes.
Strain MIC of antibiotics (mg l1) Resistance genes
Cip Tet Amp Bile salts gyrA tet(O) blaOxA cmeA cmeB cmeC
¡P þP ¡P þP ¡P þP ¡P þP
A52013 4R 0.5 <0.5S <0.5 4S 2 6250 390.6 þ e þ þ þ þ
B12013 8R 8 128R 64 32R 8 25,000 390.6 þ þ þ þ þ þ
C42013 8R 4 256R 256 2S 1 3125 390.6 þ e e e þ þ
D22013a 8R 4 64R 32 128R 64 12,500 390.6 þ þ þ þ þ þ
D22013b 32R 16 256R 256 512R 256 25,000 781.3 e þ þ e þ e
D32013 8R 8 <0.12S <0.12 2S 2 3125 195.3 þ e þ þ þ þ
D42013a 32R 16 <0.12S <0.12 8S 8 12,500 1562.5 þ e þ þ þ þ
D42013b 8R 4 64R 16 128R 64 3125 390.6 þ þ þ þ þ þ
E22013 4R 4 <0.12S <0.12 1S 1 1562.5 781.25 þ e e þ þ þ
E32013a 8R 4 <0.12S <0.12 8S 4 >25,000 >25,000 þ e þ þ þ þ
E32013b 16R 8 <0.12S <0.12 8S 4 >25,000 >25,000 þ e þ þ þ þ
E52013 8R 8 64R 32 8S 2 12,500 390.6 þ e þ þ þ þ
F12013a 4R 4 128R 128 128R 128 390.6 97.65 þ e þ þ þ þ
F12013b 8R 4 512R 256 256R 128 25,000 781.3 þ e þ þ þ þ
F22013 8R 8 128R 128 64R 64 12,500 195.3 þ e þ þ þ þ
F32013 8R 8 64R 64 64R 64 12,500 390.6 þ e þ þ þ þ
G12013 8R 4 <0.12S <0.12 4S 4 1562.5 781.3 þ e þ þ þ þ
G52013 8R 4 <0.12S <0.12 4S 4 1562.5 781.3 þ e þ þ þ þ
H42013 0.5S 0.5 0.5S 0.5 8S 8 3125 1562.5 e e þ þ þ þ
I52013 4R 4 <0.12S <0.12 4S 2 25,000 195.3 þ e þ þ þ þ
P: absence of phenylalanine-arginine b-naphthylamide (PAbN);þP: presence of phenylalanine-arginine b-naphthylamide (PAbN); Re resistant; Se sensitive; (þ)e presence
of genes; () e absence of genes. Breakpoint - ciproﬂoxacin4 mg l1 (Cip); tetracycline16 mg l1(Tet); and ampicillin 32 mg l1(Amp) (CLSI, 2012 e Enterobacteriaceae).
Values highlighted in bold indicate difference in the MIC in presence of the EPI.
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being as low as 800 cells (Black, Levine, Clements, Hughes, and
Blaser, 1988). A number of authors have quantiﬁed Campylobacter
on chicken carcasses using enumeration methods other than MPN,
and they observed that counts ranged from <1.0 to 8.0 log10 CFU
carcass1 (Chrystal, Hargraves, Boa, & Ironside, 2008; Figueroa,
Troncoso, Lopez, Rivas, & Toro, 2009; Johannessen, Johnsen,
Økland, Cudjoe, & Hofshagen, 2007; Kuana, Dos Santos, et al.,
2008; Stern et al., 2007). However, it is difﬁcult to compare re-
sults across studies, owing to the use of different materials and
enumeration methods, which consequently impedes the risk
assessment studies (Scherer et al., 2006a).
Themost prevalent species in this study was C. jejuni detected in
93.8% of positive ﬁndings, similar to what has been observed in
other studies researching prevalence of this pathogen in chicken
and by-products (Garin et al., 2012; Tang et al., 2010; Zhao et al.,
2010). The higher rate of detection of C. jejuni in several studies
may be a reﬂection of the methods used, rather than the actual
incidence in food (Lynch, Cagney, Mcdowell,& Duffy, 2011). Besides
C. jejuni and C. coli, other Campylobacter species were not detected
by our study. Nonetheless, Campylobacter lari, Campylobacter
upsaliensis, Campylobacter concisus and Campylobacter fetus have
also been isolated from chicken and by-products in other studies,
even if at a lower frequency (Garin et al., 2012; Lynch et al., 2011).
Our study also represents one of the few reports on antibiotic
susceptibility of Campylobacter spp. in chicken carcasses from
Minas Gerais, Brazil. We used disk diffusion test to perform an
initial screening in order to investigate antimicrobial resistance of
20 Campylobacter isolates against 16 antimicrobials. All Campylo-
bacter spp. evaluated in this study were resistant to at least ﬁve
antimicrobials, thus characterized as multidrug-resistant isolates.
The percentage of antibiotics to which a particular isolate was
resistant ranged from 31% to 69%. We observed a generalized
resistance to ﬁrst- and second-generation cephalosporin, namely
cephalothin, cefoxitin and cefuroxime, whereas some isolates were
susceptible to third-generation cephalosporin, cefotaxime and
ceftazidime. Surprisingly, all isolates were susceptible to cefepime,a fourth-generation cephalosporin. Similar results were observed
by Gritchina, Mishchuk, and Pozhalostina (2005), who demon-
strated high resistance of Campylobacter to the ﬁrst-generation
cephalosporins, and general susceptibility to cefepime. The ceph-
alosporins belong to a diverse class of compounds named b-lactam
antibiotics and individual differences among these molecules, such
as the amount and variety of side chains, may explain the variation
in antimicrobial resistance (Iovine, 2013). In addition, high resis-
tance of Campylobacter to b-lactams may be a consequence of se-
lective pressure caused by isolation and quantiﬁcation methods,
whose culture media are supplemented with antibiotics of this
class to inhibit enteric ﬂora contaminants (Corry, Post, Colin, &
Laisney, 1995; Jacob, Mdegela, & Nonga, 2011).
Resistance to a large number of b-lactam antimicrobial agents is
becoming more widespread in foodborne bacteria, including
Campylobacter (Li, Mehrotra, Ghimire, & Adewoye, 2007). Besides
cephalosporins, we evaluated the antimicrobial resistance of
Campylobacter to other b-lactams, including ampicillin, amoxicillin-
clavulanic acid and imipenem. We observed a high level of resis-
tance to ampicillin, which was similar to that reported in other
studies (Griggs et al., 2009; Obeng et al., 2012). In contrast, all
isolates were susceptible to imipenem, and most of them also to
amoxicillin-clavulanic acid. In previous studies, these antimicrobial
groups have also shown excellent in vitro activities against
Campylobacter spp. (Griggs et al., 2009; Hakanen, Lehtopolku,
Siitonen, Huovinen, & Kotilainen, 2003). Our results suggest that
these agents might be candidates for clinical trials in enteritis
caused by multi-drug resistant Campylobacter. Nevertheless, there
are few data on the clinical efﬁcacy of b-lactams for the treatment
of infections of this nature (Hakanen et al., 2003).
Campylobacter isolated in the present study were also suscep-
tible to gentamicin, erythromycin and chloramphenicol. Results
similar to ours were reported by other authors, who observed that
Campylobacter isolated from chicken were highly sensitive to these
three antibiotics (EFSA, 2012; NARMS, 2011; Zhao et al., 2010). In
contrast, higher resistances to these three antimicrobials were
observed by de Moura et al. (2013) and Nobile, Costantino, Bianco,
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carcasses in Brazil and Italy, respectively.
Alarmingly, we observed high resistance to quinolones (cipro-
ﬂoxacin and nalidixic acid) and tetracycline. High levels of
Campylobacter resistant to these antibiotics have also been reported
by other authors (EFSA, 2012; Mackiw et al., 2012). The rates of
resistance to quinolones and tetracycline vary worldwide, and in
the last years the high prevalence of Campylobacter spp. resistant to
these drug classes has been increasingly frequent and worrying
(Alfredson & Korolik, 2007; EFSA, 2012; Mackiw et al., 2012). These
concerns have become more severe because ﬂuoroquinolones and
tetracycline, along with macrolides, are used for treating human
infections (Mackiw et al., 2012; Obeng et al., 2012).
Overall, we observed both similarities and differences amongst
our results for antimicrobial resistance and those reported by other
authors. These variations in resistance proﬁles of Campylobacter
spp. might be expected, and occur due to the variations in the use of
antibiotics among countries, the origin and type of the samples, the
geographical distribution of resistant species and the methodology
applied to evaluate susceptibility (Wassenaar et al., 2009; Wilson,
2003; Zhao et al., 2010). The occurrence of high resistance rates
to some of the antibiotics investigated in this study could be
explained by their use as growth promoters in animal feed and
veterinary medicine (Iovine & Blaser, 2004), and reﬂects the extent
to which these antimicrobial agents are used in Brazil.
In order to investigate the molecular basis of antimicrobial
resistance of Campylobacter isolates, we evaluated the presence of
resistance and efﬂux system genes as well as the minimum inhib-
itory concentrations in the absence and presence of the efﬂux
pump inhibitor for three antibiotics selected and bile salts. Bile salts
were included in this last assay because their resistance in
Campylobacter has proved to bemediated by CmeABC efﬂux system
(Lin, Sahin, Michel, & Zhang, 2003). The high resistance to cipro-
ﬂoxacin observed in this study was strongly correlated with the
Thr-86-Ile modiﬁcation of GyrA. This mutation is the main mech-
anism of resistance to ﬂuoroquinolones in Campylobacter, and has
been frequently reported in other studies (Mackiw et al., 2012;
Wieczorek, Kania, & Osek, 2013; Zirnstein, Li, Swaminathan, &
Angulo, 1999). In our study only one isolate was resistant to cip-
roﬂoxacin and did not show the Thr-86-Ile mutation, and therefore
its resistance may be associated with other mechanisms, such as
other mutations in the gyrA, and multidrug efﬂux systems (Lin
et al., 2002; Luo, Sahin, Lin, Michel, & Zhang, 2003). On the other
hand, a relatively low percentage (40%) of the tetracycline-resistant
isolates showed the tet(O) gene, which encodes a protein that pro-
tects the ribosome from the inhibitory effect of this antibiotic (Dasti
et al., 2007). Low correlation between tetracycline resistance and
tet(O) genewas also observed by Obeng et al. (2012).Whilst, in other
studies high levels of phenotypic resistance to tetracycline were
attributed almost solely to presence of this gene (Mackiw et al.,
2012; Wieczorek et al., 2013). Beyond the tet(O) gene, nonspeciﬁc
efﬂux systems such as CmeABC multidrug efﬂux pump may
decrease susceptibility to tetracycline (Gibreel, Wetsch, & Taylor,
2007; Iovine, 2013).
Concerning the genetic basis of ampicillin resistance, all resis-
tant isolates showed the blaOxA-61 gene, which is associated with b-
lactamase production (Alfredson & Korolik, 2005). Griggs et al.
(2009) observed that 91% of the ampicillin-resistant isolates car-
ried the blaOxA-61 gene. However, it is worth noting that in our study
many susceptible isolates also showed this ampicillin resistance
gene. These results were in agreement with a previous observation
by Obeng et al. (2012). They reported that 10 of the ampicillin-
susceptible Campylobacter isolates from chicken were able to
encode the blaOxA-61 gene. Such ﬁndings indicate that the blaOxA-61
gene in these Campylobacter isolates may has been inactivated or isnot being expressed. Beyond synthesis of b-lactamases, b-lactam
resistance may also be conferred by reduced uptake due to alter-
ations in outer membrane porins and efﬂux systems (Iovine, 2013).
Great variations in bile salts resistance were observed among
Campylobacter isolates, which was consistent with the ﬁndings
from previous studies by Dzieciol, Wagner, and Hein (2011) and
Mavri and Smole Mozina (2013). The CmeABC efﬂux system plays a
key role in mediating bile salts resistance and is essential for
Campylobacter growth in bile-containing media such as the animal
intestinal tract (Lin et al., 2003). The observed difference in bile
salts resistance in our study could not be explained by failures in
the CmeABC efﬂux system, since most of the isolates showed the
three genes (cmeA, cmeB and cmeC) required for its synthesis, and
even the absence of some of them did not inﬂuence the levels of
resistance. Therefore, other mechanisms of resistance to bile salts
such as the presence of porins (Omp50 and PorA) and other efﬂux
systems (CmeDEF and CmeG) are probably involved in these results
(Akiba, Lin, Barton, & Zhang, 2006; Bolla, De, & Dorez, 2000; Bolla,
Loret, Zalewski, & Pages, 1995; Jeon, Wang, Hao, Barton, & Zhang,
2011).
The efﬂux inhibitor (PAbN) slightly decreased the MIC of cip-
roﬂoxacin, tetracycline and ampicillin, but did not restore the
susceptibility to either of them in the Campylobacter isolates. The
effects of PAbN were mostly of 2e4 fold MIC reduction for these
antibiotics. The activity of PAbN on quinolone resistance in C. jejuni
and C. coli is controversial. Our results showing the effect of PAbN
on ampicillin resistance were similar to those reported by Martinez
and Lin (2006), who observed that the MIC of b-lactams (cefotax-
ime and ampicillin) decreased 2-fold using this EPI. In another
study performed by Griggs et al. (2009) the presence of PAbN had
no effect on the MICs of b-lactams, including ampicillin, for the
Campylobacter isolates or their respective blaOxA-61 mutants. Simi-
larly, Corcoran, Quinn, Cotter, and Fanning (2005) have demon-
strated that PAbN did not produce a signiﬁcant decrease on the
resistance to quinolones in Campylobacter. However, signiﬁcant
decreases in the MIC of ﬂuoroquinolones and restoration of sus-
ceptibility in Campylobacter isolates were reported by Kurincic,
Klancnik, and Smole Mozina (2012a). With regards to tetracy-
cline, Kurincic et al. (2012a) demonstrated that PAbN caused MIC
reductions of at least 2-folde64-fold, and this EPI also restored
susceptibility to some tetracycline-resistant isolates. In contrast,
lower effects of PAbN on tetracycline MIC (1.3e2.6-fold decrease)
were observed by Gibreel et al. (2007). Although our data, as well as
those from other studies, demonstrate a lack of efﬁcacy of PAbN in
reversing ﬂuoroquinolone and tetracycline resistance, cmeB mu-
tants of Campylobacter have shown a signiﬁcant decrease in their
resistance to these antibiotics classes (Lin et al., 2002; Luo et al.,
2003). This fact suggests that the CmeABC system acts synergisti-
cally with other mechanisms to contribute to antimicrobial
resistance.
On the other hand, PAbN had a strong effect on bile salts resis-
tance in almost all isolates in our study, causing MIC reductions of
up to 128-fold. Other studies performed by Lin andMartinez (2006)
and Mavri and Smole Mozina (2013) also demonstrated that the
MICs of bile salts were dramatically decreased in the presence of
PAbN, around 16e512 fold and 2e64 fold, respectively. The
different effect of PAbN on susceptibility of antimicrobials indicates
that the inhibition occurs via binding site speciﬁc on the CmeABC
system and in a competitive manner, as suggested in previous
studies (Lomovskaya & Bostian, 2006). It has been proposed that
inhibition of multidrug efﬂux systems by EPIs is a novel approach to
enhance drug accumulation inside the bacterial cell, thereby
increasing bacterial susceptibility to antimicrobials (Lomovskaya &
Watkins, 2001). In recent years, some studies have been developed
in order to ﬁnd out new compounds which exhibit such properties
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Klancnik, & Smole Mozina, 2012b).
5. Conclusion
This work provides a baseline study on Campylobacter contam-
ination and its antimicrobial resistance and molecular basis in
chicken carcasses in Minas Gerais state, Brazil. Despite the low
prevalence and the low concentration of Campylobacter in chicken
carcass samples, the identiﬁcation of high levels of antimicrobial
resistance and multidrug-resistant isolates make this issue even
more serious. Our results point to the need for more frequent
monitoring of the prevalence and antimicrobial resistance of
Campylobacter in order to provide support for actions directed at
reducing this pathogen in the food chain. In addition, we also
suggest that efﬂux pump inhibitors may be an important tool to
reduce the antimicrobial resistance and colonization of Campylo-
bacter in animals raised for food purposes.
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